Boothbay Fund Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$7.02M Buy
318,839
+148,814
+88% +$2.59M 0.09% 219
2025
Q4
$2M Sell
170,025
-36,219
-18% -$465K 0.03% 559
2025
Q3
$3.27M Sell
206,244
-24,107
-10% -$350K 0.05% 434
2025
Q2
$2.64M Buy
230,351
+85,094
+59% +$959K 0.05% 435
2025
Q1
$1.97M Buy
145,257
+52,515
+57% +$872K 0.05% 433
2024
Q4
$1.57M Buy
92,742
+5,413
+6% +$105K 0.04% 506
2024
Q3
$1.77M Buy
+87,329
New +$1.79M 0.04% 558
2021
Q3
Sell
-11,794
Closed -$410K 1914
2021
Q2
$410K Buy
+11,794
New +$391K 0.01% 1102
2019
Q4
Sell
-19,215
Closed -$287K 862
2019
Q3
$287K Buy
+19,215
New +$313K 0.03% 585

Other funds holding CC

Boothbay Fund Management's CC Position: Q1 2026 in Review

Boothbay Fund Management increased its Chemours (CC) stake by 88% in Q1 2026, buying an estimated $2.59M and bringing the position to 318,839 shares worth $7.02M. The position accounts for 0.09% of the portfolio, ranked #219.

Boothbay Fund Management first reported a position in CC in Q3 2019 and has held it in 9 quarters since. 448 funds tracked by Wall St. Rank hold CC as of Q1 2026.

  • Boothbay Fund Management held 318,839 shares of Chemours worth $7.02M as of Q1 2026.
  • Boothbay Fund Management bought 148,814 Chemours shares in Q1 2026, an estimated $2.59M.
  • Chemours made up 0.09% of Boothbay Fund Management's portfolio in Q1 2026, its #219 holding.
  • Boothbay Fund Management first reported a position in Chemours in Q3 2019 and has held it in 9 quarters since.
  • 448 funds tracked by Wall St. Rank held Chemours as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.